肾梗死的临床表现、病因与结局:系统综述与荟萃分析
该系统综述纳入34项回顾性队列研究共12,727例肾梗死患者,采用随机效应荟萃分析合并比例。肾梗死合并发病率为0.3/10,000患者年,患病率0.017%,最常见症状为腹痛或腰痛(0.64),主要病因为栓塞性(0.42),25%的患者发展为慢性肾脏病(CKD)。
要点
- 肾梗死罕见,合并发病率0.3/10,000患者年,患病率0.017%。
- 临床表现不特异,腰痛或腹痛最常见(0.64)。
- 使用抗血栓药物不能排除肾梗死,25%的患者发展为CKD。
核心结论
- 肾梗死罕见且症状不特异,使用抗血栓药物不应排除肾梗死的鉴别诊断,25%的患者发展为CKD。
- 需要更好地标准化肾梗死的分类。
研究设计与样本
- 系统综述与荟萃分析,检索Web of Science、PubMed和Scopus数据库,筛选4010篇摘要,最终纳入34项回顾性队列研究共12,727例肾梗死病例。
- 采用随机效应荟萃分析合并比例,提供95%置信区间(95%CI),通过I²评估异质性。
主要发现
- 合并发病率为0.3/10,000患者年(95%CI 0.04-2.3;I²=99%),患病率为0.017%(95%CI 0.004-0.038;I²=99%)。
- 高血压是最常见的合并症(0.47;95%CI 0.43-0.51;I²=74%),近三分之一患者使用抗血栓治疗(0.32;95%CI 0.21-0.45;I²=88%)。
- 最常见的症状是腰痛或腹痛(0.64;95%CI 0.46-0.81;I²=89%)。
- 病因包括栓塞性(0.42;95%CI 0.35-0.50;I²=97%)、高凝状态(0.12;95%CI 0.08-0.18;I²=85%)、肾动脉损伤(0.11;95%CI 0.06-0.16;I²=97%)、创伤(0.03;95%CI 0.01-0.06;I²=87%)及其他或特发性(0.31;95%CI 0.25-0.37;I²=98%)。
- 结局包括急性透析(0.04;95%CI 0.02-0.07;I²=39%)、住院死亡率(0.05;95%CI 0.03-0.09;I²=69%)、CKD(0.25;95%CI 0.16-0.34;I²=89%)和肾衰竭(0.04;95%CI 0.02-0.08;I²=77%)。
关键数值与推荐
- 肾梗死合并发病率0.3/10,000患者年(95%CI 0.04-2.3),患病率0.017%(95%CI 0.004-0.038)。
- 高血压合并比例0.47(95%CI 0.43-0.51),抗血栓治疗比例0.32(95%CI 0.21-0.45)。
- 腰痛或腹痛比例0.64(95%CI 0.46-0.81)。
- 栓塞性病因比例0.42(95%CI 0.35-0.50),特发性及其他病因比例0.31(95%CI 0.25-0.37)。
- CKD结局比例0.25(95%CI 0.16-0.34),住院死亡率0.05(95%CI 0.03-0.09)。
临床怎么用
- 对于使用抗血栓药物且出现腰痛或腹痛的患者,仍应将肾梗死纳入鉴别诊断。
- 肾梗死后应监测肾功能,约25%的患者可能发展为CKD。
- 肾梗死病因多样,需评估栓塞、高凝状态及肾动脉损伤等可能。
局限性
- 仅纳入回顾性队列研究,存在异质性(多数I²>85%)。
- 肾梗死分类缺乏标准化,可能影响病因合并结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Renal infarction is rare with only retrospective cohort studies published. To better understand renal infarction, we conducted a systematic review and metaanalysis of proportions for i) incidence and prevalence, ii) patient characteristics and symptoms, iii) causes, and iv) outcomes. METHODS: Web of Science, PubMed, and Scopus databases were searched. Articles were screened and data extracted with pooled measures determined by random effects metaanalysis of proportions with 95% confidence interval (95% CI). Heterogeneity was examined through I 2 . RESULTS: We screened 4010 abstracts and included 34 retrospective cohort studies with 12,727 cases of renal infarction. Pooled incidence was 0.3 per 10,000 patient-years (95% CI, 0.04-2.3; I 2 = 99%) and prevalence 0.017% (95% CI, 0.004-0.038; I 2 = 99%). Comorbidity burden was high, with hypertension the most prevalent (0.47; 95% CI, 0.43-0.51; I 2 = 74%). Antithrombotic therapy was used in almost a third of patients (0.32; 95% CI, 0.21-0.45; I 2 = 88%). The most common symptom was flank or abdominal pain (0.64; 95% CI, 0.46-0.81; I 2 = 89%). Causes of renal infarction included embolic (0.42; 95% CI, 0.35-0.50; I 2 = 97%), hypercoagulable state (0.12; 95% CI, 0.08-0.18; I 2 = 85%), renal artery damage (0.11; 95% CI, 0.06-0.16, I 2 = 97%), trauma (0.03; 95% CI, 0.01-0.06; I 2 = 87%) and other or idiopathic (0.31; 95% CI, 0.25-0.37; I 2 = 98%). Outcomes following a renal infarction included acute dialysis (0.04; 95% CI, 0.02-0.07, I 2 = 39%), inpatient mortality (0.05; 95% CI, 0.03-0.09; I 2 = 69%), chronic kidney disease (CKD) (0.25; 95% CI, 0.16-0.34; I 2 = 89%), and kidney failure (0.04; 95% CI, 0.02-0.08; I 2 = 77%). CONCLUSION: Renal infarction is rare and can present with unspecific symptoms. Antithrombotic use should not exclude renal infarction from the differential and 25% develop CKD. There is a need to better standardize the classification.
引用
- Nour Eldine M, Kilan H, Hallak P, et al. Systematic Review of Renal Infarction Clinical Presentation, Causes, and Outcomes. Kidney Int Rep. 2026. PMID: 42824378. doi:10.1016/j.ekir.2026.107049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。